On July 9, 2024, Mangoceuticals, Inc., also known as MangoRx, a NASDAQ-listed company specializing in men's health and wellness products, announced a Master Distribution Agreement with ISFLST, Inc. The agreement, which was officially signed on July 9 after being dated July 2, 2024, will enable ISFLST to distribute and resell MangoRx's products, including MangoRx Grow and Mango ED, in the Asia Pacific and Latin America regions, excluding Mexico. The partnership aims to leverage ISFLST's network to promote and sell MangoRx's products, with the potential for ISFLST to earn exclusive marketing rights in these markets upon meeting certain milestones. The distribution agreement has an initial term of three years, with automatic renewals for three additional one-year terms unless terminated. The...Show More

On July 9, 2024, Mangoceuticals, Inc., also known as MangoRx, a NASDAQ-listed company specializing in men's health and wellness products, announced a Master Distribution Agreement with ISFLST, Inc. The agreement, which was officially signed on July 9 after being dated July 2, 2024, will enable ISFLST to distribute and resell MangoRx's products, including MangoRx Grow and Mango ED, in the Asia Pacific and Latin America regions, excluding Mexico. The partnership aims to leverage ISFLST's network to promote and sell MangoRx's products, with the potential for ISFLST to earn exclusive marketing rights in these markets upon meeting certain milestones. The distribution agreement has an initial term of three years, with automatic renewals for three additional one-year terms unless terminated. The agreement also includes confidentiality clauses, mutual indemnification rights, and provisions for force majeure, among other standard terms. Additionally, a press release on July 11, 2024, highlighted the strategic partnership's significance in MangoRx's expansion strategy, particularly in China and the Asia Pacific region, where there is a substantial market for men's health products. MangoRx's CEO, Jacob Cohen, expressed enthusiasm for the partnership's alignment with the company's goal to reach new international markets. ISFLST has commenced marketing activities, including establishing MangoRx Exhibits in Beijing and Hangzhou, with plans to expand to South Korea and Southeast Asia.